EN - Anglická CZ - Česká SK - Slovenská PL - Polská RO - Rumunská RU - Ruská TR - Turecká UA - Ukrajinská
EN - Anglická
  • CZ - Česká
  • SK - Slovenská
  • PL - Polská
  • RO - Rumunská
  • RU - Ruská
  • TR - Turecká
  • UA - Ukrajinská

MYXOREN, lyophilisate and solvent for parenteral injection

Homepage Products Veterinary products MYXOREN, lyophilisate and solvent for parenteral injection

Live attenuated vaccine against myxomatosis.

type of preparative: Vaccines
target species animals: Rabbit

Composition in 1 ml

Active substance

Amount

Method of administration

Poxvirus myxomatosae attenuatum

min. 103,3 TCID50

max. 105,8TCID50

s.c. (1 ml)

Poxvirus myxomatosae attenuatum

min. 102,6 TCID50

max. 105,1TCID50

i.d.

(needleless- 0,1 ml)

Poxvirus myxomatosae attenuatum

min. 102,6 TCID50

max. 105,1TCID50

ear puncture (double injection)

Aluminium hydroxide gel, sodium merthiolate, saline solution

Target species

Rabbits.

Indication

For active immunisation of rabbits against myxomatosis.

Maternal antibodies can interfere with the vaccine and therefore vaccination before
the 4th week of age is not recommended.

Route of administration and dosage

SC (subcutaneously) = 1 ml

ID (intradermally – needless) = 0.1 - 0.2 ml

Auricular (ear puncture) = 0.2 ml

Primary vaccination since the age of 10 weeks.

In myxomatosis high infection conditions, rabbits can be vaccinated since the age of 4 weeks and revaccination at the age of 10 weeks.

In breeding animals’ booster vaccination is required every 6 months.

Storage

Store in a dark and dry place at the temperature between 2 °C - 8 °C. 

Withdrawal period

None.

Shelf life

24 months.

Package

1 x 10, 1 x 20, 5 x 10, 5 x 20 subcutaneous doses.

1 x 40, 1 x 80, 1 x 50, 1 x 100, 5 x 40, 5 x 80, 5 x 50, 5 x 100 needless dose.

1 x 50, 1 x 100, 5 x 50, 5 x 100 doses applied with double needle.